<DOC>
	<DOCNO>NCT01066039</DOCNO>
	<brief_summary>This 24-week , prospective , multicenter , open-label , single-arm study assess effect bisoprolol glycemic level Type 2 diabetes mellitus ( T2DM ) control subject hypertension . The hypothesis study change glycemic level lipid metabolism determine glycosylated hemoglobin ( HbA1c ) use bisoprolol T2DM subject suboptimal blood pressure ( BP ) control .</brief_summary>
	<brief_title>Phase 4 Study Assess Effect Bisoprolol Glycemic Level Type II Diabetic Subjects With Suboptimal Blood Pressure Control</brief_title>
	<detailed_description>Diabetes mellitus hypertension two common chronic condition , predisposes accelerate atherosclerosis , cardiovascular disease , death . There concern beta-blocker might adverse effect subject diabetes glucose metabolism , data show highly beta-1 selective agent bisoprolol essentially free metabolic disturbance involve blood sugar , insulin sensitivity lipid . This prospective , multicenter , single-arm , open-label study assess glycemic effect bisoprolol T2DM subject suboptimal BP control . After pre-screening period , enrol subject T2DM suboptimal BP control undergo laboratory test efficacy safety measurement . After , subject continue his/her usual dosage antihypertensive medication bisoprolol add . Subjects instruct continue diet level physical activity attempt maintain current body weight completion study . Bisoprolol titrate upward dosage lower BP le 130/80 millimeter mercury ( mmHg ) first 2 month treatment . The maximum dosage bisoprolol 10 mg daily . Following 6 month add bisoprolol therapy , efficacy safety measurement repeat . The duration study 24 week subject . Objectives Primary objective : - To assess effect bisoprolol glycemic control measure change baseline HbA1c T2DM subject suboptimal BP control Secondary objective : - To evaluate effect bisoprolol , add-on therapy , BP T2DM subject suboptimal BP control - To evaluate effect bisoprolol , add-on therapy , insulin sensitivity determine Homeostasis Model Assessment-Insulin Resistance ( HOMA-IR ) - To evaluate effect bisoprolol , add-on therapy , lipid metabolism determine lipid profile T2DM subject suboptimal BP control - To evaluate safety tolerability bisoprolol T2DM subject suboptimal BP control - To assess effect bisoprolol combination therapy insulin c-peptide T2DM subject suboptimal BP control compare baseline - To assess effect bisoprolol combination therapy microalbumin albumin/creatinine ratio T2DM subject suboptimal BP control compare baseline</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Bisoprolol</mesh_term>
	<criteria>Age 20 year old less 80 year Subjects T2DM Subjects fail achieve appropriate BP level result treatment antihypertensive drug beta blocker , BP inadequately control great equal ( &gt; = ) 130/80 mmHg . However , use beta blocker 12 week enrol Subjects underwent stable antidiabetic regimen 12 week prior screen Signed write informed consent Ongoing insulin therapy Change two HbA1c level measure interval 4 week longer previous 6 month least 1 % ( last HbA1c measure within 4 week ) Secondary hypertension Subjects renal impairment ( creatinine great 150 micromol per liter 1.7 milligram per deciliter ) Cardiovascular disease ( uncontrolled symptomatic arrhythmia , unstable angina , sick sinus syndrome , second third degree atrioventricular ( AV ) block , bradycardia [ le 50 beat per minute ] , congestive heart failure , myocardial infarction , cerebral infraction attach within 12 week ) Subjects require BP control least 3 different antihypertensive drug , either systolic blood pressure ( SBP ) &gt; =180 mmHg diastolic blood pressure ( DBP ) &gt; =110 mmHg baseline Subjects type 1 diabetes mellitus ( T1DM ) Uncontrolled diabetes HbA1c &gt; 9 % BMI &gt; 40 kilogram per square meter ( kg/m^2 ) Pulmonary disease ( chronic obstructive pulmonary disease [ COPD ] , bronchial asthma ) Other patient consider investigator eligible participation study legal mental reason Contraindications betablocker Pregnant lactate woman Use investigational drug within 30 day entry study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Bisoprolol</keyword>
	<keyword>Hypertension</keyword>
	<keyword>Diabetes mellitus , Type II</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Glycemic level</keyword>
</DOC>